Coherentmarketinsightsus

  Dementia is one of the most common age-related medical conditions. As we age, mental processes and memory become affected by changes in the brain, resulting in problems with memory, attention, mood, and behavior. Dementia can occur in anyone, although it is more common in elderly adults and people suffering from other mental disorders such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, and post-traumatic stress disorder. Market Dynamics High prevalence of dementia is expected to propel growth of the dementia drugs market . For instance, according to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. R&D of new drugs is expected to offer...

  Dementia is an application of disease that affects the functioning of the brain causing decline in memory or other thinking skills. Alzheimer's disease is the most typical and largest type of dementia (in over 60% cases), that is observed among people aged 65 years and above. Accumulation of a protein called beta amyloid in the spaces between nerve cells because of genetic mutation is really a major cause of dementia. Although dementia isn't treatable, symptomatic treatment is followed in most cases. Research will be carried out to develop therapies devoted to the role of beta-amyloid in dementia. Major factor fueling growth of the Dementia Drugs Market includes, increasing amount of drugs in the pipeline, which are likely to enter into the marketplace by 2020-2022. Based on the study published by Translational Research and Clinical Intervention, in September 2017, 105 new drugs have been in pipeline, out of which 25 have been in phase one, 52 in phase two...

  Dementia is one of the most common age-related medical conditions. As we age, mental processes and memory become suffering from changes in the brain, resulting in problems with memory, attention, mood, and behavior. Dementia can occur in anyone, though it is more common in elderly adults and people struggling with other mental disorders such as for instance depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, and post-traumatic stress disorder. Market Dynamics High prevalence of dementia is expected to propel growth of the Dementia Drugs Market . For example, in accordance with Alzheimer's Association, around 5.8 million people in the U.S. aged 65 and older are coping with Alzheimer's dementia in 2020. Moreover, increasing geriatric population can also be expected to aid in growth of the market. For example, based on the U.S. Census Bureau, the U.S. geriatric population is expected to attain 77 million by 2034. R&D...